The preferred timing of treatment of nonculprit lesions in patients with ST-segment elevation myocardial infarction (STEMI) ...

Five-year data from the PARTNER 3 trial showed that among low-risk patients with severe, symptomatic aortic stenosis, ...

An 82-year-old woman with a history of congestive heart failure was admitted to this hospital for volume overload. Ascites, ...

Patients with muscle-invasive bladder cancer have varied outcomes after cystectomy. Circulating tumor DNA (ctDNA)–based ...

In the phase 3 EMBARK trial, enzalutamide plus leuprolide and enzalutamide monotherapy were associated with longer metastasis ...

Patients with previously untreated, locally advanced, unresectable or metastatic triple-negative breast cancer who are not ...

Recognizing that half of eligible children are not enrolled in the supplementary nutrition program for women, infants, and ...

Geographic atrophy due to age-related macular degeneration (AMD) is the leading cause of irreversible blindness and affects more than 5 million persons worldwide. No therapies to restore vision in ...

Dr. Heidi S. Park (Medicine): A 43-year-old woman was admitted to the psychiatry service of this hospital because of depressed mood and suicidal ideation. The patient had been in her usual state of ...

Teclistamab, a T-cell engager targeting B-cell maturation antigen, showed promise as a rescue therapy in 10 patients with refractory autoimmune diseases and led to clinical and serologic improvemen ...

Human epidermal growth factor receptor 2 (HER2)–directed antibody–drug conjugate monotherapy has shown preliminary clinical efficacy in patients with chemotherapy-refractory HER2-positive locally ...